Executive summary
Get Better is the system a person runs to reach Longevity Escape Velocity alive, healthy, and still wanting more life. Longevity Escape Velocity (LEV) is the point where science adds more than one year of remaining life expectancy for every calendar year that passes.
Three technological pathways could get humanity there: cellular age reversal, structural replacement, and preservation of a minimal biological form. They are arriving on different timelines, and none has arrived yet. The people who benefit will be the ones who stay biologically eligible, resourced, connected, and purposeful long enough to meet them.
The demographic evidence says the wait is real. Across the longest-lived populations, life expectancy at birth rose about 6.5 years between 1990 and 2019, well below the twentieth-century pace. Survival to 100 is unlikely to exceed 15% for women and 5% for men this century without therapies that slow aging itself (Olshansky et al., Nature Aging, 2024).
Get Better works on the person doing the waiting. Each of its three parts supplies something the bridge requires:
- Self-Awareness keeps the Human regulated and the Being clear. The Life Quality Score traces how a life feels back to the factors producing it.
- The GB Framework gives a 100-plus-year life a renewable reason to continue: Calling as a repeating cycle of Learn, Master, Improve, Transcend, carried by the Growth Foundation of Health, Connection, and Resources.
- The Life Transformation System turns the vision into the 168 hours of each week, which is where healthspan is preserved or spent.
What Longevity Escape Velocity is
LEV is reached when remaining life expectancy grows faster than time passes: each year of progress adds more than a year to how long a living person can expect to live. Today the ratio runs the other way. It takes more than a year of research to add a year of expected life.
The concept came from David Gobel, co-founder of the Methuselah Foundation. Biogerontologist Aubrey de Grey coined the term in a 2004 PLOS Biology paper and popularized it in Ending Aging (2007, with Michael Rae). It also goes by actuarial or biological escape velocity (Wikipedia).
The field's leading voices put it within the working lifetime of most adults alive today:
| Forecaster | Forecast | When stated |
|---|---|---|
| Ray Kurzweil, futurist | LEV between 2029 and 2035, accelerated by AI simulation of biology | 2024, The Economist (revised from 2028 to 2030, stated in 2018) |
| Aubrey de Grey, biogerontologist | A 50% chance of LEV by 2036 | Stated on X |
| David Sinclair, Harvard geneticist | The first person to live to 150 has already been born | January 2023, Harvard Gazette |
| George Church, Harvard geneticist | "Wouldn't be surprised if 2050 would be a point" | August 2025, Dwarkesh Patel interview |
Critics point out that LEV would be a statistic about a population, not a promise to any individual. It would not mean everyone has access to rejuvenation therapies, and it would not remove deaths unrelated to aging. The distance between a population milestone and a personal one is what the rest of this report addresses.
The demographic reality
Curing diseases one at a time can no longer move human lifespan much. Deaths now cluster in a narrow band of old age, so removing any single cause shifts the average by months, not decades. Only a change in the rate of biological aging itself breaks that pattern.
| Measure | Figure |
|---|---|
| Life expectancy gain, high-income nations, 20th century | About 30 years, roughly 3 per decade |
| Average gain in the longest-lived populations, 1990 to 2019 | About 6.5 years, roughly 0.22 per year |
| Pace that would count as radical life extension | 0.3 years per year, sustained |
| Cost of one more year at the top (Japan, 2019) | 20.3% fewer deaths at every age for women (88 to 89); 9.5% for men (82 to 83) |
| Survival to 100, current birth cohorts (average) | 5.1% of women, 1.8% of men |
| Survival to 100, Hong Kong (highest) | 12.8% of women, 4.4% of men |
| Survival to 100, best rates of every population combined | 13.9% of women, 4.5% of men |
| Projected ceiling this century | 15% of women, 5% of men |
| Effect of eliminating every death before age 50 | +1.0 year for women, +1.5 for men |
The study modeled what a life expectancy of 110 would take for Japanese women, the world's longest-lived group. Death rates at every age up to 150 would need to fall 88% below the 2019 rate at age 109. Seventy percent of women would have to reach 100, 24% would have to pass Jeanne Calment's record of 122, and 6% would have to reach 150.
The conclusion is narrow and useful. Radical extension is implausible this century under the current medical model. It becomes plausible only if gerotherapeutics change the rate of aging, and the people positioned to benefit are the ones still in good condition when they do.
Why linear forecasts understate what's coming
The demographic data describes the end of one curve, and AI is shortening the time it takes to start the next one.
Intuition forecasts in straight lines: take the last decade's progress and extend it. Technologies rarely move that way. They tend to follow an S-curve, with slow early gains, a steep middle where progress compounds, and a plateau as the approach matures. The rate of change along that curve is bell-shaped: small at first, peaking in the steep middle, falling off at maturity. Everett Rogers described adoption the same way in Diffusion of Innovations, a bell curve of new adopters that adds up to an S-curve of total use.
A straight line drawn from a plateau misses the next curve
The Olshansky study measures 1990 to 2019, the plateau of medicine that treats diseases one at a time. If gerotherapeutics work, they start a new curve rather than extending the old line. A plateau is where a straight-line forecast looks most convincing and is most likely to miss the next inflection. It cuts both ways: a new curve isn't guaranteed, and its timing is the open question.
AI is compressing the slowest steps in biology:
| Development | What happened |
|---|---|
| AlphaFold | About 200 million predicted protein structures across more than a million organisms, against roughly 190,000 determined experimentally over the previous 60 years. Nobel Prize in Chemistry, 2024 (EMBL). |
| AI-found senolytics | A neural network screened 804,959 compounds for drugs that clear senescent cells; three candidates matched an established reference compound (Nature Aging, 2023). |
| Rentosertib | Target identified and molecule designed with AI. In a Phase 2a trial of 71 patients with pulmonary fibrosis, the 60 mg arm gained 98.4 mL of lung capacity while placebo lost 20.3 mL (Nature Medicine, June 2025). |
| GPT-4b micro | OpenAI and Retro Biosciences redesigned two Yamanaka reprogramming factors, SOX2 and KLF4; in the lab the variants produced more than 50 times the expression of stem cell reprogramming markers (OpenAI, August 2025; company report, not yet peer reviewed). |
AI speeds up finding targets, designing molecules, and screening candidates. Human trials still run on biological time, because a therapy that slows aging has to be watched over years in people. That explains why forecasters like Kurzweil pulled their LEV estimates forward on the strength of AI, and why the bridge still matters. The steep part of the next curve may arrive within a lifetime, and a person has to be in condition to meet it.
The three pathways to radical life extension
All three pathways are timeline bets, and each one asks the person to still be here, and still be themselves, when it matures.
| Pathway | What it does | Where it stands | Main barrier |
|---|---|---|---|
| 1. Cellular health and age reversal | Slows or reverses aging at the cellular level instead of treating diseases after they appear. Exosome therapeutics, gerotherapeutic compounds, biological age modulation. | Animal results are real: in the NIA Interventions Testing Program, astaxanthin extended median lifespan in male mice by 12% and meclizine by 8% (GeroScience, 2023). Exosome developers such as Kimera Labs entered the $101M XPRIZE Healthspan as 2025 semifinalists (announcement). | No therapy has yet shown it changes the rate of human aging. |
| 2. Physical upgrades and replacement | Replaces failing structures when cellular repair cannot prevent them: mechanical hearts, artificial kidneys, engineered tissue, genetically modified animal organs. | Devices and early xenotransplants exist; durable, routine replacement does not. | Surgical risk, immune rejection, integration with the rest of the body. |
| 3. Minimal biological form | Sustains only the biology the brain needs to function; nothing is replaced. Ocular and other sensory input is replicated by bloodstream nanotechnology or other interfaces. | Speculative as a whole system. Individual senses already have working demonstrations (see below). | Interface complexity, unknown cognitive durability, and the open question of whether the person who persists is still the same person. |
The value of getting Pathway 1 right is enormous. Slowing aging enough to add one year of life expectancy is worth an estimated $38 trillion; ten years is worth $367 trillion (Scott, Ellison and Sinclair, Nature Aging, 2021).
Pathway 3 in depth: rebuilding the sensory world
The brain never touches the world directly. It receives electrical signals from the senses and builds a model of the world from them, so a preserved brain fed the right signals could inhabit a virtual world that feels physically real.
Neuroscientist Anil Seth describes perception as the brain's running prediction about the causes of its sensory input, constantly checked against incoming signals: "we're all hallucinating all the time" (MIT Technology Review, 2021). For Pathway 3 that changes the engineering goal. The interface doesn't have to reproduce the world. It has to deliver signals the brain's model accepts as the world: a cool breeze, the aroma of food, position, depth, height, motion.
Pathway 3 swaps the source of the signal, not the brain that reads it
Every sense in the lower row has to be written in separately. Several already have early human demonstrations.
| Sense | Closest working demonstration | Status |
|---|---|---|
| Touch (pressure, location, edges, motion on the skin) | Stimulating the brain's touch cortex produced sensations that stayed in the same spot on the hand for years, a gliding feel across the fingers, and letters traced on a fingertip (Pitt and UChicago, Science and Nature Biomedical Engineering, 2024 to 2025) | Human trials |
| Touch: temperature (warmth, cool air) | Temperature arrives through the skin but on its own receptors and pathway. In mice it is processed in a separate "thermal cortex" in the posterior insula, with distinct neurons for cool and warm; switching it off stopped thermal perception (Nature, 2023). An interface that writes pressure would not produce a breeze. | Mapped in animals; no device |
| Balance (position, head motion, orientation) | A head-worn motion sensor drives the vestibular nerve directly; eight patients improved on posture and gait, and some returned to cycling and dancing (Johns Hopkins, NEJM, 2021) | Human trials |
| Hearing (sound) | The cochlear implant, a routine clinical device; the balance implant above is an adapted version of it | Clinical use |
| Smell (aroma, much of flavor) | Electrodes in the sinus cavity produced smells (onion, antiseptic, sour, fruity) in three of five people (Mass Eye and Ear, 2018) | Early human research |
| Sight (light, dark, shape, position, depth) | Neuralink's Blindsight stimulates the visual cortex directly; FDA Breakthrough Device designation in 2024, no human implant as of August 2026, early vision expected to be low resolution (MobiHealthNews, Pulse) | Pre-human |
Delivery through the bloodstream. The vascular route is real but so far runs in one direction. Synchron's Stentrode is threaded through the jugular vein into a blood vessel over the motor cortex; six patients had no serious device-related events over a year (COMMAND study, 2024). It reads movement intent out of the brain and does not yet write sensation in. Wirelessly powered magnetoelectric nanoparticles have stimulated deep brain tissue in freely moving mice after injection (bioRxiv, 2020). Nanotech that travels the bloodstream and writes full sensory signals is still theoretical.
What remains unsolved.
- Integration. Depth, height, and motion have no single channel. The brain assembles them from vision, balance, and body position at once, and when those signals disagree it flags the mismatch; motion sickness is the everyday version. A sensory world has to keep every channel in agreement, in real time.
- Resolution. Each demonstration above carries a narrow slice of one sense. A convincing world needs all of them at full fidelity.
- The model itself. The brain's model of the world was built over a lifetime in a body. A preserved brain brings that model with it, which is why replicated signals could feel real. It also brings its threat settings, emotional patterns, and sense of purpose. The interface supplies the world; the person still has to be someone worth continuing.
The bridge problem
Reaching LEV takes two things from the individual: arriving eligible, and wanting to arrive.
Arriving eligible. Early gerotherapeutics are being tested as ways to slow decline, so the condition a person brings to them matters. Metabolic health, cardiovascular capacity, cognitive reserve, and a nervous system that isn't running a chronic threat response are the starting balance any future therapy works from. So are the money, network, and access to reach the therapy when it exists.
Wanting to arrive. An average life is about 4,000 weeks. LEV removes that ceiling, and the question shifts from how many weeks remain to what the weeks are for. The nervous system reads coasting and stagnation as a threat, which is why a comfortable life can still feel off. More years of that state is not a prize. A longer life needs a reason to keep growing that renews itself, or the added time fills with the same flatness at greater length.
Medicine is working on the first condition. Far less attention goes to the second, and the two depend on each other: a person with no reason to continue rarely does the daily work that keeps them eligible.
Muscle and mitochondria: combating sarcopenia
Skeletal muscle is the body's largest metabolic organ, and its mitochondria, the structures that turn fuel into usable energy, decline with age. Mitochondrial dysfunction and disabled autophagy, the cell's recycling of damaged parts, are two of the twelve hallmarks of aging (López-Otín et al., Cell, 2023). In aging muscle, damaged mitochondria build up when that recycling slows, driving inflammation, atrophy, and sarcopenia (Aging, 2023).
Strength and fitness are among the strongest predictors of survival ever measured, and both still respond to training late in life:
| Measure | Finding |
|---|---|
| Grip strength | Each 5 kg drop in grip strength carried a 16% higher risk of death from any cause, across 139,691 adults in 17 countries (Lancet, 2015) |
| Cardiorespiratory fitness | Among 122,007 patients, the fittest had 80% lower mortality than the least fit; poor fitness carried as much risk as smoking, diabetes, or heart disease, or more (JAMA Network Open, 2018) |
| Training response with age | Interval training raised mitochondrial capacity 69% in adults aged 65 to 80, against 49% in adults aged 18 to 30; resistance training built more muscle mass (Mayo Clinic, Cell Metabolism, 2017) |
| Urolithin A | In 66 adults aged 65 to 90, this mitophagy-activating compound improved hand and leg muscle endurance at two and four months; ATP production and six-minute walk distance did not change (JAMA Network Open, 2022) |
The largest prize in aging research defines youth partly in these terms. The $101M XPRIZE Healthspan asks teams to restore muscle, cognitive, and immune function by at least 10 years, with a goal of 20, in people aged 50 to 80, using a treatment that lasts a year or less (XPRIZE).
Combating sarcopenia, the age-related loss of muscle mass and strength, is a priority for both healthspan and escape velocity. It is also a clear case of the Xerox Effect: as cells keep copying themselves, mitochondria lose efficiency, and muscle, with its heavy energy demand, is where that loss shows up as weakness and fatigue.
Interval training does the most for mitochondria and resistance training the most for muscle mass, so a week that holds both builds both. The Get Better baseline is strength training three to four times a week and at least 150 minutes of zone 2 cardio, a pace where you can still hold a conversation. Past seventy, protecting muscle outranks almost everything else, extended fasting included.
In GB terms this is Physical health in the Growth Foundation and a fixed allocation in the Life Transformation System. A therapy that slows aging works on whatever muscle and mitochondrial capacity a person still has when it arrives.
Get Better as the bridge
Each part of the Get Better system answers one of the two bridge conditions: Self-Awareness and the Life Transformation System keep a person eligible, and the GB Framework keeps them wanting to arrive.
Calling rests on the Growth Foundation, carried by Self-Awareness and the week
Calling sits on the three pillars of the Growth Foundation. Self-Awareness is the ground they stand on, and the Life Transformation System is where all of it gets lived, week by week.
1. Self-Awareness: regulate the Human, clarify the Being
Human is the brain, body, nervous system, and biological drives. Being is consciousness, purpose, and direction. A long life is a Human achievement, and it only matters if the Being has somewhere to go.
On the Human side, most adults still run threat settings calibrated in childhood, when disconnection or judgment could feel life-threatening. An email, a curt remark, or an awkward conversation fires physiology built for falling or fleeing. Left on, that response narrows thinking, pulls people away from connection, and adds physical wear year after year.
Recalibration works in four steps:
- Name the threat as an error message popping up on a screen: "Error: I am being judged." "Error: I am being left out." Seeing it as a message on a screen creates distance from it.
- Trace it back to where the feeling first formed.
- Score the real danger now, from 0 to 10. Most modern triggers score near zero for physical risk.
- Reassure the younger self who set the original alarm, so the system can stand down.
Self-Awareness also holds the four biological drives (Connect, Create, Impact, Growth), emotional vibration as the readout of the state a life is in, and the Life Quality Score that traces it (see Measurement, below).
2. The GB Framework: a reason to continue that renews itself
Calling is the reason for living, and it points a direction rather than naming a destination. It runs as a cycle: Learn, Master, Improve, Transcend, then Learn again. A 4,000-week life holds a handful of cycles. A life with no fixed ceiling needs the cycle to keep purpose from running out, and Transcend is the step that opens a new domain instead of plateauing in the last one.
Calling rests on the Growth Foundation's twelve components. Each one is a place where a long life either compounds or erodes.
From Calling and the Growth Foundation, a person assesses where they are now and where they want to be, then builds a three-to-five-year vision on framework-based vision board templates. It's design thinking applied to your life: understand the current state, define the one you want, design toward it, and iterate.
3. The Life Transformation System: where the work gets done
The Life Transformation System is where change is manifested. The vision says where you're going; this is where you do the work to get there. You can do anything, but you can't do everything, so the system decides what comes first. And you can't start with the second floor. Change is built from the foundation up.
It helps you do the right thing and do the thing right. The right thing comes from the vision and the gaps the assessment reveals. Doing it right comes from how the 168 hours of each week are allocated and which habits carry the plan: sleep, training, nutrition, recovery, relationships, focused work, learning. Kept up week after week, this is the layer that keeps a person eligible for Pathway 1 while the science matures.
What each pathway asks of the person
Every pathway is a technology, and every one of them still lands in a human life. Read through the GB lens, each pathway draws on a different part of the system.
| Pathway | What it asks of the person | Where Get Better supplies it |
|---|---|---|
| 1. Cellular age reversal | A body still worth slowing down: metabolic and cardiovascular health, cognitive reserve, a low chronic stress load, and the consistency to adopt early evidence. | Health (Physical, Mental, Emotional). The Life Transformation System for daily habits. Self-Awareness for nervous system regulation. |
| 2. Physical replacement | The money and access to reach a procedure, people to navigate it and recover with, and a nervous system steady enough to come through major surgery as the same person. | Resources (Wealth, Network, Experience). Connection (Love, Family). Health (Emotional, Spiritual). |
| 3. Minimal biological form | A self worth preserving and a clear sense of what that self is once most of the body is gone. | Being. Calling and Spiritual health. Here the Human and Being distinction stops being a teaching model and becomes the practical question. |
Pathway 3 is where Get Better's oldest distinction meets the frontier. If the Human can be pared back to a brain and an interface, what persists is the Being: purpose, direction, identity. A person who has never examined their Being has nothing deliberate to carry forward.
The longevity economy and the Calling cycle
A longer life breaks the three-stage model of learn, earn, retire, and the Calling cycle is the structure that replaces it at the level of the individual.
Andrew Scott, author of The 100-Year Life and The Longevity Imperative, describes the shift as moving from an aging society, which counts dependency ratios, to a longevity economy, which reorganizes the whole life course around multiple stages: extended careers, mid-life transitions, re-education, caregiving, renewal. A multi-stage life is a series of Calling cycles. Each stage runs Learn, Master, Improve, Transcend, and Transcend is the handoff into the next stage's Learn.
The main financial risk changes with it. The old risk was dying too early. The new one is outliving your assets, skills, health, and sense of purpose. The Resources pillar was built for this, because it defines resources as more than money:
| Resources component | What it protects across a long life |
|---|---|
| Wealth | Runway for re-education, pivots, and a decades-long drawdown phase |
| Reputation | The ability to re-enter a field or open a new one at fifty, seventy, or ninety |
| Network | Access to opportunity, care, and the next stage's teachers |
| Experience | Accumulated skill and judgment that compound instead of going stale |
Of the three market segments in longevity (an extended middle age, the silver economy of late-life care, and the evergreen economy of lifelong prevention and learning), Get Better belongs to the evergreen economy. It serves a person at any age, and its value grows with the number of years ahead.
Measurement: biological age and life quality
Biological age tells you how fast the Human is aging. The Life Quality Score tells you whether the life being extended is worth living, and what to change.
The longevity field already measures the body well: epigenetic clocks, VO2 max, metabolic panels, imaging. Those numbers answer one question about extra years. They leave out the second: what those years feel like and where they are heading.
The Life Quality Score works in three layers:
- Output: emotional vibration. The overall state a life is in. A person living their best life shows a high average emotional vibration.
- Inputs: the Growth Foundation. Health, Connection, and Resources, supporting Calling.
- Tracer: the Life Quality Score. It decomposes the state into the factors producing it, the way a sleep score breaks a poor night into duration, stages, and disruptions against an ideal.
Longitudinally, the score links what a person was trying to become with what they did and whether they got there. A wearable holds biometrics without context. Get Better holds the context. Over a large population, that record lets the system move from describing a life to forecasting one. An illustrative read: "Your plan as written: 57% confidence. Remove alcohol +9, cardio four times a week +7, cut working hours 10% +7. Adjusted plan: 80% confidence."
Paired, the two measures cover the whole bridge. Biological age tracks eligibility. The Life Quality Score tracks the will and the direction to use it.
Synthesis matrix
The three pathways and the demographic constraint describe what science must do; the Get Better column describes what the person must do to be there for it.
| Dimension | Pathway 1: Cellular | Pathway 2: Replacement | Pathway 3: Minimal form | Demographics and economics | Get Better |
|---|---|---|---|---|---|
| Mechanism | Exosomes, gerotherapeutics, biological age modulation | Artificial organs, xenotransplantation, engineered tissue | Brain preservation, synthetic and virtual interfaces | Life-table analysis, multi-stage life course | Self-Awareness, Calling on the Growth Foundation, the Life Transformation System |
| Barrier | Changing the rate of human aging | Surgical risk, rejection, integration | Interface complexity, identity continuity | Gains slowed to about 0.22 years per year; survival-to-100 ceiling | Childhood threat settings, stagnation, purpose that runs out |
| Value | +1 year life expectancy = $38T; +10 years = $367T | Device and surgical markets | Unknown | Healthspan extension across the life course | A person who arrives eligible and wants to arrive |
| Goal | Reverse cellular age, extend healthspan | Preserve function by replacing parts | Sustain identity beyond the body | Align policy, pensions, and care with a 100-year life | Reach LEV with the Human regulated and the Being clear |
Key takeaways
- Science has to change the rate of aging. Curing diseases one by one cannot produce radical life extension; the life-table math rules it out. Gerotherapeutics are the only route that changes the outcome.
- Institutions have to plan for a multi-stage life. Pensions, insurance, and employers built around learn, earn, retire will fail a population living 100 years or more.
- Individuals have to arrive eligible and wanting to arrive. That means a regulated nervous system, a Growth Foundation strong in Health, Connection, and Resources, a Calling that renews through Learn, Master, Improve, Transcend, and a week built to protect all of it. Get Better is the system for that part of the bridge.
Sources
- Olshansky, S. J. et al. Implausibility of radical life extension in humans in the twenty-first century. Nature Aging, October 2024. Coverage: UIC Today, Neuroscience News.
- Scott, A. J., Ellison, M., Sinclair, D. A. The economic value of targeting aging. Nature Aging, 2021.
- NIA Interventions Testing Program. Astaxanthin and meclizine extend lifespan in UM-HET3 male mice. GeroScience, 2023.
- Kimera Labs named semifinalist in the $101M XPRIZE Healthspan, May 2025. XPRIZE Healthspan finalists and Milestone 2 awardees, August 2026.
- Longevity escape velocity. Wikipedia, for the definition, origin, and forecasts by Kurzweil, de Grey, Sinclair, and Church.
- López-Otín, C. et al. Hallmarks of aging: an expanding universe. Cell, 2023.
- Mitochondrial fitness sustains healthy muscle aging. Aging, 2023.
- Leong, D. P. et al. (PURE). Grip strength and mortality. The Lancet, 2015.
- Mandsager, K. et al. Cardiorespiratory fitness and long-term mortality. JAMA Network Open, 2018.
- Robinson, M. M. et al. Interval training and mitochondrial capacity in older adults. Cell Metabolism, 2017.
- Liu, S. et al. Urolithin A in older adults. JAMA Network Open, 2022.
- XPRIZE Healthspan competition goals.
This report reviews published research for a general audience. It is not medical advice.
About Get Better Lab
Get Better Lab applies systems thinking to human development. Its Get Better framework is a neuroscience-based system that bridges survival biology and conscious purpose. The Life Quality Score is a proprietary measure of how alive and fulfilled a life feels, regardless of how successful it may appear from the outside. The Get Better platform is available at getbetterapp.com.
About the author
Dean Whitney is the founder of Get Better Lab and author of Get Better: A Neuroscience-Based Framework for Human Development. He is a Harvard Medical School–trained life coach (Lifestyle and Wellness Coaching) and certified neuroscience coach, with nearly three decades as a strategic leader in emerging technology, systems design, and product innovation.
